FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/11/2024
Voltar para busca
Dado oficial do USPTO
HISTOCYTE LABORATORIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
09/11/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
08/12/2021
Data de registro
23/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/04/2024
Última transação
23/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "HISTOCYTE" in dark green stylized font over the wording "LABORATORIES" in stylized font, with the letter "L" in dark green and the wording "ABORATORIES" in light green. The bottom of the "H" in "HISTOCYTE" is connected to the top of the "L" in "LABORATORIES", all inside a dark green rectangular carrier. The color white represents background and is not claimed as a feature of the mark.
Titulares e representantes
Titulares
HistoCyte Laboratories Ltd
Representantes
Mari-Elise Paul McBrayer PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; diagnostic preparations for scientific or research use; chemical preparations for scientific purposesother than for medical or veterinary use; reagents for scientific purposes; reagents for medical research; reagents for research purposes; diagnostic reagents for scientific or research use; biochemical reagents used for non-medical purposes; diagnostic reagents for in-vitro use other than medical or veterinary purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; reagents for analytical purposes other than for medical or veterinary purposes; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; chemical reagents for use in diagnostic testsother than for medical or veterinary use; chemical products for diagnostic and scientific useimmunohistochemistry ("IHC") cell line controls for slide control of samples and tissue samples; chemical products for scientific use other than medical or veterinary purposes; chemical substances for analysis in laboratoriesother than for medical or veterinary purposes; chemicals for use in analysis other than medical and veterinary purposes; chemicals for use in scientific analysis other than medical and veterinary purposes; diagnostic preparations for scientific purposes; diagnostic testing materialsother than for medical use; diagnostic chemicals other than for medical or veterinary use
Classe 5
Medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; diagnostic reagents for medicinal use; chemical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for use in diagnostic tests for medical purposes; reagents and media for medical and veterinary diagnostic purposes; medical diagnostic reagents and assays for testing of body fluids; biological tissue cultures for medical purposes; diagnostic agents for medical use; in vitro diagnostic preparations for medical use; pharmaceutical preparations in the nature of quality control preparations for use in connection with immunohistochemistry and in situ hybridisation assays
Classe 42
Biochemistry research services; cell culture services for scientific and research purposesfor others; cell separation research services; research and development in the pharmaceutical and biotechnology fields; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development in the field of diagnostic preparations; scientific and technological design servicesdevelopment of tissue diagnostic assays for running clinical trial assays for the analysis of cancer biomarkers in the field of cancer research and diagnosis; scientific and technological servicesdevelopment of tissue diagnostic assays for running clinical trial assays for the analysis of cancer biomarkers in the field of cancer research and diagnosis; consultancy in the field of biotechnology; industrial analysis and research in the field of cancer research and diagnosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/10/2024
FIMP
FINAL DISPOSITION PROCESSED
23/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
23/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2024
GPNX
NOTIFICATION PROCESSED BY IB
06/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2024
PUBO
PUBLISHED FOR OPPOSITION
06/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/01/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/12/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/11/2023
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
02/10/2023
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
02/10/2023
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
02/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/09/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/06/2023
GNFR
FINAL REFUSAL E-MAILED
23/06/2023
CNFR
FINAL REFUSAL WRITTEN
23/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2023
RFNT
REFUSAL PROCESSED BY IB
22/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/11/2022
RFRR
REFUSAL PROCESSED BY MPU
25/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/09/2022
CNRT
NON-FINAL ACTION WRITTEN
16/09/2022
DOCK
ASSIGNED TO EXAMINER
16/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
28/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HISTOCYTE LABORATORIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.